Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Deutsche Bank analyst Steve Powers downgrades Colgate-Palmolive (NYSE:CL) from Buy to Hold and raises the price target from ...
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $119 to $122.
An initiative seeking to enable easier unionization in the cannabis industry in Oregon got the green light from the secretary o...
Cannabis producer and the operator of Sunnyside dispensaries Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) released on T...
TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $110 to $115.
Bernstein analyst Callum Elliott maintains Colgate-Palmolive (NYSE:CL) with a Market Perform and raises the price target fro...
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024
